JNNP

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

Journal of Neurology, Neurosurgery, and Psychiatry 2006;77:289; doi:10.1136/jnnp.2005.080192
Copyright © 2006 by the BMJ Publishing Group Ltd.

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schwark, C
Right arrow Articles by Schellinger, P D
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schwark, C
Right arrow Articles by Schellinger, P D
Topic Collections
Right arrowRelevant Article

EDITORIAL COMMENTARY

Thrombolytic therapy

Is old age really a reason to withhold thrombolytic therapy?

C Schwark, P D Schellinger

Department of Neurology, University of Heidelberg, Germany

Correspondence to:
Correspondence to:
Dr Peter D Schellinger
Neurologische Universitätsklinik, Im Neuenheimer Feld 400, D-69120 Heidelberg, Germany; Peter_Schellinger@med.uni-heidelberg.de


Patients eligible for thrombolysis should be treated regardless of age

Keywords: old age; rt-PA; thrombolysis

The first 150 words of the full text of this article appear below.

Van Oostenbrugge et al (see pages 375–7) of this issue present data on a group of 45 patients aged 80 years or over and compare outcome after thrombolytic therapy to that in a group of patients aged less than 80 years. In their study, older patients have a significantly worse outcome as measured by the modified Rankin scale. There was a non-significant trend towards more intracranial bleeding in the older patients. The authors conclude that their results "question whether the use of rt-PA [recombinant tissue plasminogen activator] is justified in patients over 80 years of age".

The authors are ambivalent with regard to thrombolytic therapy, and even more so when it comes to the treatment of elderly patients. As stated in their article, the Third International Stroke Trial (IST3) might answer some of the apparently open questions.1 This trial so far has included 408 patients . . . [Full text of this article]


Relevant Article

Thrombolysis for acute stroke with special emphasis on the very old: experience from a single Dutch centre
R J van Oostenbrugge, R M M Hupperts, and J Lodder
J. Neurol. Neurosurg. Psychiatry 2006 77: 375-377. [Abstract] [Full Text] [PDF]






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2006 by the BMJ Publishing Group Ltd.